-
COVID-19: Government’s expert panel allows clinical trials for third dose of Covaxin
Bharat Biotech presented amendments to the subject expert committee of DCGI in the approved Phase 2 clinical trial protocol for administration of boos
-
Covid-19: India records 72,330 new cases, highest single day rise
Experts have recommended speeding up the inoculation drive by scaling up capacity with collaboration with private providers to contain the rapidly inc
-
Almost 65% Indians intend to travel for leisure, adventure in 2021: Survey
The survey revealed that the rollout of vaccines and pragmatic innovations across the travel chain seem to have contributed to this increase in consum
-
Mumbai records 88,710 COVID-19 cases in March, 475% rise as compared to February
As per the data, the virus claimed 216 lives in the financial capital of the country in March, a rise of around 181% as compared to the death toll of
-
Third phase of vaccination drive for people aged above 45 to begin tomorrow in Delhi
The third phase of the COVID-19 vaccination drive is slated to span 192 health facilities, including 136 private hospitals in the national capital on
-
Pfizer says its COVID-19 vaccine protects younger teens
Pfizer announced that its COVID-19 vaccine is safe and strongly protective in kids as young as 12
-
COVID-19 cases | Cannot afford to be complacent: Centre to states
All states and Union Territories are reporting a surge in cases
-
Adar Poonawalla says hopes to launch Covovax trials in India by September 2021
In August 2020, American vaccine company Novavax had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373
-
Centre plans to bring more population groups under vaccination drive: Harsh Vardhan
The countrywide vaccination drive was rolled out on January 16 with healthcare workers getting inoculated first and immunisation of frontline workers
-
Vaccine: SBI General Insurance to cover cost for low-income beneficiaries in Maharashtra, Andhra Pradesh
This initiative will provide free COVID-19 vaccination to more than 37,000 beneficiaries, covering senior citizens and people with co-morbidities in s
